CLASS II ONGOING Device recall · Reported 17 Jan 2024 · FDA Enforcement Report

aView 2 A Monitor recalled by Ambu

Ambu is recalling aView 2 A Monitor, distributed nationwide in the US. The recall was initiated on 5 Dec 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog No. 405011000 - UDI-DI 5707480145089 Catalog No. 405011000US2 - UDI-DI 5707480156757 All products distributed since launch (May 2020)
Quantity recalled11845 distributed US

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0714-2024
FDA event ID
93599
Recalling firm
Ambu, Columbia, MD
Classification
Class II
Status
Ongoing
Recall initiated
5 Dec 2023
FDA classified
11 Jan 2024
Reported
17 Jan 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Device type
Patient Monitors

Timeline

5 Dec 2023Recall initiated by company
11 Jan 2024Classified by FDA+37 days
17 Jan 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Instructions for Use have been updated to add the following warning: Use only M4 screws with the length of 14 16 mm when mounting Ambu aView 2 Advance on a VESA interface. Using longer screw lengths will penetrate the lithium-ion battery and result in a fire hazard and battery leakage which can cause severe burns, smoke inhalation and skin irritation. Using shorter screw lengths could result in unsecure device fastening.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Ambu aView 2 A Monitor, Catalog numbers 405011000 and 405011000US2

Where it was distributed

Domestic distribution nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Instructions for Use have been updated to add the following warning: Use only M4 screws with the length of 14 16 mm when mounting Ambu aView 2 Advance on a VESA interface. Using longer screw lengths will penetrate the lithium-ion battery and result in a fire hazard and battery leakage which can cause severe burns, smoke inhalation and skin irritation. Using shorter screw lengths could result in unsecure device fastening.

Which lots are affected?

Catalog No. 405011000 - UDI-DI 5707480145089 Catalog No. 405011000US2 - UDI-DI 5707480156757 All products distributed since launch (May 2020)

Where was it sold?

Domestic distribution nationwide.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ambu

All 7
ReportedClassRecallCompanyReasonWhere
DeviceCLASS ISpur II Labeled as the following recalled by AmbuAmbuOtherNationwide
DeviceCLASS IIaScope" 5 Broncho HD 5.6/2.8 Sampler Set recalled by AmbuAmbuLabeling ErrorsNationwide
DeviceCLASS IIAmbu¿ VivaSight 2 DLT Endobronchial tube recalledAmbuOtherNationwide
DeviceCLASS IIaView 2 A Monitor-The Ambu aView 2 Advance is intended recalledAmbuDevice MalfunctionNationwide
DeviceCLASS IIVivaSight 2 DLT recalled by AmbuAmbuPackaging DefectsNationwide

Other Patient Monitors recalls

All 1,022